Related Experiment Video
Updated: Aug 29, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Evaluation of Crocin Effect on Contrast-Induced Nephropathy Following Coronary Angiography or Angioplasty: A
Lida Shojaei1, Shima Esfandiary1, Mohammad Rouzbahani2
1Department of Clinical Pharmacy, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Insights
Crocin effectively prevents contrast-induced nephropathy (CIN) in chronic kidney disease patients undergoing angiography. This study found significantly lower CIN incidence with crocin compared to standard hydration alone.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Contrast-induced nephropathy (CIN) is a significant cause of hospital-acquired acute kidney injury.
- Current prophylactic strategies for CIN, primarily antioxidant therapy and hydration, show limited efficacy.
- Chronic kidney disease (CKD) patients are at high risk for CIN following contrast media exposure.
Purpose of the Study:
- To evaluate the efficacy of crocin as a prophylactic agent against CIN in CKD patients undergoing coronary angiography/angioplasty.
- To assess the impact of crocin on serum creatinine and urinary NGAL levels post-contrast media exposure.
- To determine the incidence of CIN in CKD patients treated with crocin versus standard care.
Main Methods:
- A randomized clinical trial involving 110 CKD stage 3 patients undergoing coronary angiography/angioplasty.
- Patients received standard hydration; the intervention group received 30 mg oral crocin doses for three consecutive days.
- CIN incidence was defined by serum creatinine increase (≥ 0.3 mg/dL) or urinary NGAL changes within 48 hours of contrast media exposure.
Main Results:
- No significant increase in serum creatinine was observed in the crocin group within 48 hours of the procedure.
- Urinary NGAL levels showed no significant changes in either the crocin or control group.
- CIN incidence was significantly lower in the crocin group (1.75%) compared to the control group (13.2%; P = 0.028).
Conclusions:
- Crocin administration demonstrates a significant nephron-protective role in preventing CIN in CKD patients.
- Crocin represents a promising therapeutic strategy to reduce CIN incidence in at-risk patient populations.
- Further research may explore optimal dosing and long-term effects of crocin for CIN prevention.
Abstract:
Contrast-induced nephropathy (CIN) is the third cause of hospital-acquired acute kidney injury. The CIN prophylactic strategies adopted to date, although not highly efficient, are mostly based on antioxidant activity and hydration therapy. This study was designed and conducted to evaluate crocin's efficacy in the prevention of CIN in chronic kidney disease (CKD) patients undergoing coronary angiography/angioplasty. In this randomized clinical trial, a total of 110 eligible CKD stage 3 patients requiring contrast agent administration for coronary angiography/angioplasty were enrolled and randomly assigned to either crocin (n = 57) or control (n = 53) group. The patients in both groups received standard hydration therapy; nevertheless, in the crocin group, the patients were also orally administered three consecutive oral doses of 30 mg crocin tablets 1 day before up to 1 day after contrast media (CM) exposure. The primary endpoint was CIN incidence defined as an increase in serum creatinine (SrCr) level by ≥ 0.3 mg/dL or any change in urinary neutrophil gelatinase-associated lipocalin (NGAL) from the baseline within 48 hours of CM exposure. During 4 months, 130 patients were recruited. The mean age of the patients was 65.62 ± 9.05 years, and the majority of them were male (64.54%). The SrCr in the crocin group did not significantly increase within 48 hours of angiography/angioplasty. The changes in the urinary NGAL level were not significant in both groups. The CIN incidence was significantly lower in the crocin group than in the control group (1.75% and 13.2%; P = 0.028). Crocin administration plays an important nephron-protective role in the prevention of CIN.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Cardiac Catheterization I: Pre-Procedure Overview
Imaging Studies VII: Vascular Imaging
Coronary Artery Disease V: Interprofessional Care
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome III: Diagnostic Studies

